EDC
One size does not fit all
Safety Notification
RTSM
Deliver powerful randomization methods
CODER
Fast and accurate clinical coding
Drug and Device Logistics
Mitigate risk and create closer connections
eTMF
Essential document collection
CTMS
Accelerate your trial and ensure data integrity
eCONSENT
Meet patients where they are
eCOA
Faster, cleaner and more reliable data
Patient Poll
Quick insights from patients
eCRF Setup
Capture better data, faster
eTMF Setup
Get up and running in no time
PV Management
Identify and handle your safety management needs
Data Management
Make more informed business decisions
Submission and Data Mapping
Move and consolidate data
eTechnology Strategy
Integrate and capitalize on critical technologies
Protocol Development
Turning your research question into a study
Observational Studies
Digital, cost effective and time efficient
Primary Market Research
Direct to patient, unique, and quality data
IRB and EC Management
End to end regulatory management
PV and GDPR Compliance
Safety, consent and data protection
Scientific Communications
Results dissemination
Digital Communications
Increase patient awareness
Data Linkage
Generate, combine and analyze data
I’m Gilda Teissier, Marketing Director at EvidentIQ and I recently met with Simon Taylor, Director of Solution Consulting at EvidentIQ Modern Clinical trials have undergone a huge shift in the
Are you interested in Virtual Trials? You have heard about it, but not sure whether this approach is the most appropriate for you? You want
I’m Gilda Teissier, Executive Marketing Director at EvidentIQ and I recently met with Lise Radoszycki, COO at Carenity and Global Head of Data Science at EvidentIQ. Over the past decade,
Are you interested in Preference studies? You have heard about DCE, but not sure whether this approach is the most appropriate for you? You want
I’m Gilda Teissier, Executive Marketing Director at EvidentIQ and I recently met with Michael Chekroun, Founder and CEO at Carenity and Chief Strategy and Transformation Officer at EvidentIQ Group for
My interview with EvidentIQ CEO Andreas Weber These days we see a lot of critical coverage of the approval of new vaccines in numerous markets. The reporting of
EvidentIQ Group GmbH Grosse Johannisstr. 7, 20457 Hamburg, Germany.
Copyright 2022 EvidentIQ
All Rights Reserved
Commercial Register: Hamburg HRB 147319
Sales Tax Identification Number: DE312852940
Managing Directors
Andreas Weber, Manuel Neukum, Axel Jansen, Lars Kloppsteck,
Helge Hofmeister
Commercial Register: Hamburg, HRB 147319
Sales tax identification number: DE312852940
Follow us:
Managing Directors
Andreas Weber, Manuel Neukum, Axel Jansen, Lars Kloppsteck,
Helge Hofmeister, Franciscus Pijpers
Franciscus Pijpers
Commercial Register
Hamburg, HRB 147319
